318 related articles for article (PubMed ID: 20201480)
1. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty.
Lachiewicz PF
Orthopedics; 2009 Dec; 32(12 Suppl):74-8. PubMed ID: 20201480
[TBL] [Abstract][Full Text] [Related]
2. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
Colwell CW
Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
[TBL] [Abstract][Full Text] [Related]
3. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
4. Unanswered questions, unmet needs in venous thromboprophylaxis.
Cushner FD; Nett MP
Orthopedics; 2009 Dec; 32(12 Suppl):62-6. PubMed ID: 20201478
[TBL] [Abstract][Full Text] [Related]
5. DVT prophylaxis: better living through chemistry: affirms.
Pellegrini VD
Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
[TBL] [Abstract][Full Text] [Related]
6. New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty.
Friedman RJ
Orthopedics; 2009 Dec; 32(12 Suppl):79-84. PubMed ID: 20201481
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence.
Stewart DW; Freshour JE
Ann Pharmacother; 2013 Jan; 47(1):63-74. PubMed ID: 23324504
[TBL] [Abstract][Full Text] [Related]
8. Rationale for thromboprophylaxis in lower joint arthroplasty.
Colwell CW
Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
[TBL] [Abstract][Full Text] [Related]
9. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
[TBL] [Abstract][Full Text] [Related]
10. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership.
Mesko JW; Brand RA; Iorio R; Gradisar I; Heekin R; Leighton R; Thornberry R
J Arthroplasty; 2001 Sep; 16(6):679-88. PubMed ID: 11547365
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolic disease after total hip and knee arthroplasty.
Haas SB; Barrack RL; Westrich G
Instr Course Lect; 2009; 58():781-93. PubMed ID: 19385586
[TBL] [Abstract][Full Text] [Related]
13. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.
Anderson FA; Hirsh J; White K; Fitzgerald RH;
Chest; 2003 Dec; 124(6 Suppl):349S-356S. PubMed ID: 14668417
[TBL] [Abstract][Full Text] [Related]
14. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?
Eikelboom JW; Karthikeyan G; Fagel N; Hirsh J
Chest; 2009 Feb; 135(2):513-520. PubMed ID: 19201714
[TBL] [Abstract][Full Text] [Related]
15. Deep venous thrombosis prophylaxis for total joint arthroplasty: American Academy of Orthopaedic Surgeons guidelines.
Parvizi J; Azzam K; Rothman RH
J Arthroplasty; 2008 Oct; 23(7 Suppl):2-5. PubMed ID: 18922368
[TBL] [Abstract][Full Text] [Related]
16. Prevention of symptomatic pulmonary embolism in patients undergoing total hip and knee arthroplasty: clinical guideline of the American Academy of Orthopaedic Surgeons.
Lachiewicz PF
Instr Course Lect; 2009; 58():795-804. PubMed ID: 19385587
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism: management by American Association of Hip and Knee Surgeons.
Markel DC; York S; Liston MJ; Flynn JC; Barnes CL; Davis CM;
J Arthroplasty; 2010 Jan; 25(1):3-9.e1-2. PubMed ID: 19837560
[TBL] [Abstract][Full Text] [Related]
18. Current guidelines for total joint VTE prophylaxis: dawn of a new day.
Barrack RL
J Bone Joint Surg Br; 2012 Nov; 94(11 Suppl A):3-7. PubMed ID: 23118370
[TBL] [Abstract][Full Text] [Related]
19. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
20. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
